Signal transduction, the cell cycle, and development. Furthermore, our SUMO conjugated proteome should serve as a rich resource for those studying the roles of sumoylation in metazoan development. This quantitative review confirmed that RNA and CD4 have very different time patterns of Mechlorethamine hydrochloride clinical prognostic value during untreated HIV-1 infection. Within the first 2 years of infection, RNA immediately gives some indication of long-term prognosis. Due to constant relative risks and constant within-population variability, RNA remains similarly informative when measured during later years. CD4, in contrast, carries little prognostic value over early years. Its within-population variability then instead largely relates to pre-infection CD4 levels, which vary by up to a factor ten among uninfected adults without influencing prognosis after infection. As infection progresses and worsening immune deficiency allows opportunistic infections and AIDS-defining illnesses to occur, the prognostic value of CD4 increases, due to strong increases in relative prognostic risks per unit CD4 decrease and increasing proportional within-population variability in CD4 levels. Part of the prognostic value may reflect that OI themselves temporarily reduce CD4 and increase RNA 2 effects that may be common in clinic populations where the occurrence of OIs is often the reason for diagnosis, especially in Africa. For relative risk studies, data analyzed were Gentamycin Sulfate limited to untreated cohorts and did not address toxicity, viral resistance and cost associated with ART. We nevertheless believe 
that the findings are important for clinical decision making, because the prior question that physicians face is their patients�� prognosis if treatment is not initiated. Furthermore, despite our attempts to include only high-quality studies and to focus on standardized outcomes with known covariates, our pooled analyses are not meta-analyses in the strict sense. Notably, included studies varied in rates of loss to follow-up, extent of exposure to antiretroviral mono- or bi-therapy, OI prophylaxis and treatment, and patient inclusion criteria and age ranges; however, available data and statistical power precluded optimal assessment of these possible determinants. The capability of gene expression microarrays to simultaneously measure essentially all human genes has made possible a variety of approaches to analyzing biological samples.